Bases de datos bibliográficos Pascal y Francis

Ayuda

Exportación

Selección :

Enlace permanente
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22575932

Combination of Alfuzosin and Tadalafil Exerts an Additive Relaxant Effect on Human Detrusor and Prostatic Tissues In Vitro

Autor
OGER, Stephanie1 ; BEHR-ROUSSEL, Delphine1 ; GORNY, Diane1 ; LEBRET, Thierry2 ; DENOUX, Yves2 ; ALEXANDRE, Laurent1 ; GIULIANO, François3
[1] Pelvipharm, Orsay Parc, Batiment Cedre, 86 rue de Paris, 91400 Orsay, France
[2] Foch Hospital, Department of Urology, Suresnes, France
[3] AP-HP, Neuro-Uro-Andrology, Department of Physical Medicine and Rehabilitation Raymond Poincaré Hospital, Garches, France
Fuente

European urology. 2010, Vol 57, Num 4, pp 699-707, 9 p ; ref : 32 ref

CODEN
EUURAV
ISSN
0302-2838
Campo Científico
Urology, nephrology
Editor
Elsevier, Kidlington
País de la publicación
United Kingdom
Tipo de documento
Article
Idioma
English
Palabra clave de autor
Bladder Lower urinary tract symptoms PDE5 inhibitor Prostate Smooth muscle α1-adrenoceptor antagonist
Palabra clave (fr)
Additif Alfuzosine Antagoniste Homme In vitro Muscle detrusor Muscle lisse Néphrologie Prostate Récepteur α1-adrénergique Tadalafil Tissu Troubles urinaires du bas appareil Urologie Vasodilatateur Vessie urinaire 3',5'-Cyclic-GMP phosphodiesterase Appareil urinaire Appareil urogénital Bloquant α-adrénergique Dérivé de la carboline Dérivé de la quinazoline Enzyme Esterases Hydrolases Inhibiteur de la phosphodiesterase Inhibiteur de la phosphodiestérase 5 Inhibiteur enzyme Pathologie de l'appareil urinaire Pathologie des voies urinaires Phosphoric diester hydrolases Trouble de la miction
Palabra clave (in)
Additive Alfuzosin Antagonist Human In vitro Detrusor muscle Smooth muscle Nephrology Prostate α1-Adrenergic receptor Tadalafil Tissue Lower urinary tract symptoms Urology Vasodilator agent Urinary bladder 3',5'-Cyclic-GMP phosphodiesterase Urinary system Urogenital system Alpha blocking agent Carboline derivatives Quinazoline derivatives Enzyme Esterases Hydrolases Phosphodiesterase inhibitor Phosphodiesterase 5 inhibitor Enzyme inhibitor Urinary system disease Urinary tract disease Phosphoric diester hydrolases Voiding dysfunction
Palabra clave (es)
Aditivo Alfuzosina Antagonista Hombre In vitro Músculo detrusor Músculo liso Nefrología Prostata Receptor α1-adrenérgico Tadalafilo Tejido Trastornos urinarios baja aparato Urología Vasodilatador Vejiga 3',5'-Cyclic-GMP phosphodiesterase Aparato urinario Aparato urogenital Bloqueador α-adrenérgico Enzima Esterases Hydrolases Inhibidor phosphodiesterase Inhibidor fosfodiesterasa 5 Inhibidor enzima Aparato urinario patología Vía urinaria patología Phosphoric diester hydrolases Trastorno micción
Clasificación
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14E Urinary system involvement in other diseases. Miscellaneous / 002B14E02 Urinary tract. Prostate gland

Disciplina
Nephrology. Urinary tract diseases
Procedencia
Inist-CNRS
Base de datos
PASCAL
Identificador INIST
22575932

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Acceso al documento

Buscar en la web